Active tDCS for Early Multiple Sclerosis

"The age bracket for this trial is 23 to 59. However, there are alternatives available depending on the patient's age: 26 trials cater to those younger than 18 and 243 other studies target patients over 65."

"Affirmative. According to the clinicaltrials.gov website, this trial is currently enrolling participants. It was originally posted on January 18th 2022 and last updated September 13th of that year. A total of 50 individuals are required from one medical facility for participation in the study."

"This study aims to measure Intra-Individual Variability (IIV) over the course of 4 minutes, evaluated with Cogstate Brief Battery (CBB). Secondary objectives include gauging a patient's cognitive impairment via three distinct tests: The Symbol Digit Modalities Test (SDMT), which is used as a general screening tool for severe cognitive dysfunction; the Brief Visuospatial Memory Test Revised (BVMT-R); and Rey Auditory Verbal Learning Test (RAVLT). Each test scores range from 0 - 110, 12 or 36 respectively, with lower scores indicating more serious levels of mental deterioration."

"Affirmative. According to clinicaltrials.gov, this medical trial is currently in search of participants - the first posting was on January 18th 2022 and it has been updated most recently on September 13th 2022. The study requires 50 volunteers at 1 particular site."

"This medical research requires the participation of 50 individuals between 23 and 59 years old who have been diagnosed with multiple sclerosis. Furthermore, these patients must either possess radiologically isolated syndrome that has lasted no more than 6 months from their initial MRI scan or clinically isolated syndrome ≤ 3 months from first clinical event for eligibility."